Copyright
©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 101724
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.101724
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.101724
Figure 2 Impact of Yinchenhao decoction on bilirubin, liver function, urine output, and liver cell histology in rats with obstructive jaundice.
A and B: Development of obstructive jaundice (OJ) rat models; C-F: Bilirubin (C), liver function (D), bile acid (E), and urine output (F) in rats with OJ. aP < 0.05 vs group S; bP < 0.01 vs group S; cP < 0.05 vs group O; dP < 0.01 vs group O; G: Histological alterations in liver and kidney tissues of rats with OJ. Group O: Obstructive jaundice model; group S: Sham; Y Group: Yinchenhao decoction-treated; TSBA: Total serum bile acid; DBIL: Direct bilirubin; TBIL: Total bilirubin; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; Clr: Renal clearance; TUBA: Total urinary bile acid.
- Citation: Liu JJ, Mei HW, Jing YY, Li ZL, Wu SG, Yuan HX, Zhang XB. Yinchenhao decoction alleviates obstructive jaundice liver injury by modulating epidermal growth factor receptor and constitutive androstane receptor signaling. World J Hepatol 2025; 17(3): 101724
- URL: https://www.wjgnet.com/1948-5182/full/v17/i3/101724.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i3.101724